Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)neurotoxicity in mice

By Yokoyama Hironori   Yano Ryohei   Kuroiwa Hayato   Tsukada Tatsuya   Uchida Hiroto   Kato Hiroyuki   Kasahara Jiro   Araki Tsutomu  

Metabolic Brain Disease, Vol. 25, Iss. 2, 2010-06 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice

By Yokoyama Hironori   Yano Ryohei   Kuroiwa Hayato   Tsukada Tatsuya   Uchida Hiroto   Kato Hiroyuki   Kasahara Jiro   Araki Tsutomu  

Metabolic Brain Disease, Vol. 25, Iss. 3, 2010-09 ,pp. : 305-313

Springer Publishing Company

Access to resources Recommend Favorite

Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model

By        

International Journal of Molecular Medicine, Vol. 36, Iss. 5, 2015-01 ,pp. : 1369-1376

Spandidos Publications

Access to resources Recommend Favorite

Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine

By Ortiz Genaro   Pacheco-Moisés Fermín   Gómez-Rodríguez Víctor   González-Renovato Erika   Torres-Sánchez Erandhis   Ramírez-Anguiano Ana  

Metabolic Brain Disease, Vol. 28, Iss. 4, 2013-12 ,pp. : 705-709

Springer Publishing Company

Access to resources Recommend Favorite

Transcranial Direct Current Stimulation Ameliorates Behavioral Deficits and Reduces Oxidative Stress in 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Mouse Model of Parkinson's Disease

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 18, Iss. 6, 2015-08 ,pp. : 442-447

John Wiley & Sons Inc

Access to resources Recommend Favorite